Biological E to Launch Safety Surveillance Study for its Single-Dose Typhoid Vaccine to Detect Adverse Events - Newshunt | Latest and Breaking News, India News & World News

Biological E to Launch Safety Surveillance Study for its Single-Dose Typhoid Vaccine to Detect Adverse Events

Multicentre phase-IV clinical study will be performed in 12 study centres in India. It aims to evaluate the safety of a single intramuscular dose of Biological E’s typhoid conjugate vaccine in participants aged six months to 45 years


from India News Today: India Live News | Latest India News Online | Current News Headline News18
Read The Rest:indianexpress...

No comments:

Powered by Blogger.